U.S. federal trademark · Serial No. 99222386
Scientific study and research in the field of cancer therapy, namely, through the identification of T-cells targeting oncogenic driver peptides
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.